Clinical Investigation for a Multifunction Ophthalmic Measurement Device
NCT ID: NCT06565091
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
378 participants
INTERVENTIONAL
2024-06-10
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The results of this clinical investigation will be used to refine and validate the device design.
378 participants total will be included in the trial, each having only one visit at the investigation center.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a New Device and Method to Assess the Degree of Myopia and/or Astigmatism in Myopic People
NCT07297810
Comparative Study and Validation of New Methodologies for Measuring Addition
NCT06963138
Refractive Status and Accommodation Response Under Different Experimental Conditions.
NCT06331780
Measuring the Peripheral Optical Quality of The Eye
NCT03479827
Long Term Effects of Multifocal Orthokeratology on Corneal and Choroidal Structures in Healthy Subjects With Myopia- A Pilot Study
NCT02700295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Develop the device in clinical conditions (refine the intensity and gain of the light sources and the acquisition time of the cameras and photodiodes, in order to cover the targeted population).
* Evaluate the safety and clinical performance and/or effectiveness of the medical device and determine whether the system is suitable for the purposes and populations for which it is intended.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multifonction Ophtalmic Measuring Device
Parameters and images of the anterior and posterior chambers of the human eye
Measurements of physiological parameters of the anterior chamber
Acquisition by the investigational device
Measurements of the Axial biometry
Acquisition by the investigational device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measurements of physiological parameters of the anterior chamber
Acquisition by the investigational device
Measurements of the Axial biometry
Acquisition by the investigational device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Participants initially coming to the center for a routine consultation
Participants who are affiliated to a social security scheme or beneficiaries of such a scheme (L. 1121-8-1 of the Public Health Code of "Code de Santé Publique"),
Participants able to sit upright in front of the investigational device.
Healthy children ≥ 4 years and \<18 of age. The parents must have consented to their child's participation.
Children who are affiliated to parent's social security scheme or beneficiaries of such a scheme (L. 1121-8-1 of the Public Health Code of "Code de Santé Publique")
Children initially coming to the center for a routine consultation
Children able to sit upright in front of the instrument.
Exclusion Criteria
Participants not able to sit upright in front of the instrument or subjects with forehead or chin injuries which prevent the head from being supported on the forehead / chin rest.
Participants who are deprived of their liberty by judicial or administrative decision and persons hospitalized without their consent (Article L. 1121-6 of "Code de Santé Publique"),
Participants who are subject to a legal protection measure (curatorship, guardianship, safeguard of justice ...) or unable to express their consent (Article L1121-8 of "Code de Santé Publique"),
Participants who are not affiliated to a social security scheme or beneficiaries of such a scheme (L. 1121-8-1 of the Public Health Code of "Code de Santé Publique"),
Participants under exclusion period from another investigation,
Women who are pregnant or breastfeeding women; (Article L1121-5 of "Code de Santé Publique"). No additional risk had been identified for pregnant woman in participating in the investigation. Nevertheless, pregnancy induces ocular changes: in case of AE, the causality with the device or with pregnancy may be difficult to establish, justifying the non-inclusion of this population.
Participants with neurologic disorder, particularly epileptic or sensory motor troubles,
Participants with history of recent ocular surgeries (including refractive surgery less than 2 weeks),
Participants who are ESSILOR International/ESSILOR Luxottica employees,
Participants with monophthalmia,
Participants with obvious fixation disorder, strabismus, or nystagmus,
For tonometry measurements: subjects who have: Edematous/ulcerated cornea, following keratoplasty or ocular surgery, following penetrating trauma, severe Keratoconus with risk of hydrops and in case of retinal detachment. Anterior and posterior chamber sulcus IOL, intrastromal rings or lens (type Kamra).
Participants with pupil \< 2 mm,
Participants who are with spherical equivalent refraction out of the range -20.00 to + 20.00 D (frontofocometer measurement),
Participants with an astigmatism greater than 8.00 D (\<8.00 D) (frontofocometer measurement),
Participants with corneal power out of the range \[35-55D\],
Participants with axial length out of the range \[18-34 mm\],
Participants with Intraocular pressure out of \[7-50 mm Hg\] range,
Participants to a previous phase of this clinical investigation.
Children with neurologic disorders, particularly epileptic or sensory motor troubles,
Children with history of recent ocular surgeries (including refractive surgery less than two weeks)
Children with monophthalmia,
Children with obvious fixation disorder, strabismus, or nystagmus,
Children with pupil \< 2 mm
Children with a spherical equivalent refraction out of the range \[-20.00 to + 20.00 D\] (frontofocometer measurement),
Children with an astigmatism higher than 8.00 D (\>8.00 D)
Children with axial length out of the range \[18-34 mm\]
4 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Essilor International
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François LE GUYADER, Dr
Role: PRINCIPAL_INVESTIGATOR
WEST OPHTA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Ophta
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
FRANCOIS LE GUYADER, Dr
Role: primary
PIERRE-EMMANUEL ARCADE, Dr
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01481-44
Identifier Type: OTHER
Identifier Source: secondary_id
WS10339
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.